Literature DB >> 32352509

Response to: Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan).

Luigi Petramala1, Claudio Letizia1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32352509     DOI: 10.1093/ehjcvp/pvaa035

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


× No keyword cloud information.
  1 in total

1.  Sacubitril/valsartan in COVID-19 patients: the need for trials.

Authors:  Domenico Acanfora; Marco Matteo Ciccone; Pietro Scicchitano; Chiara Acanfora; Gerardo Casucci
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2020-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.